How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Buy
56
KLAC Quote, Financials, Valuation and Earnings
Last price:
$679.34
Seasonality move
:
3.82%
Day range:
$655.42 - $681.14
52-week range:
$609.40 - $896.32
Dividend yield:
0.93%
P/E ratio:
28.59x
P/S ratio:
8.46x
P/B ratio:
25.20x
Volume:
1.2M
Avg. volume:
1.1M
1-year change:
-2.69%
Market cap:
$90.3B
Revenue:
$9.8B
EPS (TTM):
$23.78
KLAC Analysts' Consensus Rating
The 21 analysts providing 12-month price projections for KLA shares anticipate an average target of $820.53, ranging from a low estimate of $655.00 to a high estimate of $950.00. This average target implies a growth of 20.7% compared to the current stock price of $679.80.
Consensus Price Target
$820.53
Highest Price Target
$950.00
Lowest Price Target
$655.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 11 | 12 | 11 |
| Hold | 12 | 10 | 10 |
| Sell | 0 | 0 | 0 |
| Consensus | Hold | Buy | Buy |
KLAC Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is up 109.21% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.
Buy
74
COOP alert for Apr 1
Mr. Cooper Group [COOP] is up 14.4% over the past day.
